SEC Form 4 · accession 0001104659-15-054389
Vitae Pharmaceuticals, Inc · VTAE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John M. Leonard
Director
Period of report
Jul 29, 2015
Accepted (ET)
Jul 29, 2015 · 5:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001157602
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $9.85 | Jul 29, 2015 | A | 20,000 | A | — | Jul 28, 2025 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1The option will vest in quarterly installments over three years following 7/29/2015.